Uniphar plc (AIM:UPR)
London · Delayed Price · Currency is GBP · Price in GBX 346.10
-0.90 (-0.26%)
Sep 9, 2025, 2:39 PM GMT+1
Uniphar Market Cap
Uniphar has a market cap or net worth of 909.85 million as of September 9, 2025. Its market cap has increased by 48.63% in one year.
Market Cap
909.85M
Enterprise Value
1.22B
Revenue
2.48B
Ranking
n/a
PE Ratio
16.01
Stock Price
346.10
Market Cap Chart
Since July 17, 2019, Uniphar's market cap has increased from 284.47M to 909.85M, an increase of 219.85%. That is a compound annual growth rate of 20.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 909.85M | 90.09% |
| Dec 31, 2024 | 478.64M | -25.17% |
| Dec 29, 2023 | 639.68M | -14.79% |
| Dec 30, 2022 | 750.70M | -34.52% |
| Dec 31, 2021 | 1.15B | 96.94% |
| Dec 31, 2020 | 582.17M | 106.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 185.62B |
| GSK plc | 58.98B |
| Haleon | 32.14B |
| Smith & Nephew | 12.27B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.76B |
| HUTCHMED (China) | 1.98B |
| Genus | 1.75B |